drugset / Trial / NCT02104414

Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy

NCT02104414 ↗

Phase 4 Terminated 11 enrolled St. Luke's-Roosevelt Hospital Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the quality and duration of pain relief after a hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more effective postoperative pain relief than both bupivacaine hcl and the control.

Timeline

Start
2014-04
Primary completion
2016-01
Completion
2016-01

Outcome

Outcome not reported

Stopped (Enrollment): “low enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 75 mg Other
Comparator Bupivacaine Other / unclassified 266 mg Other
Comparator Epinephrine Other / unclassified — Other

Indications